(Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q9)Sep 30, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | -95.43%9.87M | 5.96%352.87M | 95.99%216.14M | -13.19%333.04M | --110.28M | 32.39%383.65M | --276.49M | 33.33%289.79M | --217.34M |
Operating income | -95.43%9.87M | 5.96%352.87M | 95.99%216.14M | -13.19%333.04M | 110.28M | 32.39%383.65M | 276.49M | 33.33%289.79M | 217.34M |
Cost of sales | 92.29%-10.27M | -5.11%-235.44M | -46.31%-133.24M | -4.67%-223.99M | ---91.07M | -32.98%-213.99M | ---158.13M | -31.43%-160.93M | ---122.45M |
Operating expenses | 92.29%-10.27M | -5.11%-235.44M | -46.31%-133.24M | -4.67%-223.99M | -91.07M | -32.98%-213.99M | -158.13M | -31.43%-160.93M | -122.45M |
Gross profit | -100.48%-394K | 7.69%117.43M | 331.38%82.91M | -35.72%109.05M | 19.22M | 31.66%169.66M | 118.35M | 35.79%128.86M | 94.9M |
Selling expenses | 89.56%-604K | 26.44%-13.69M | -44.35%-5.78M | 18.81%-18.61M | ---4.01M | -12.34%-22.92M | ---17.13M | -22.46%-20.4M | ---16.66M |
Administrative expenses | 71.32%-10.28M | -22.83%-60.44M | -95.33%-35.83M | -2.34%-49.2M | ---18.34M | -60.68%-48.08M | ---35.2M | -7.44%-29.92M | ---27.85M |
Research and development expenses | 94.35%-956K | -5.46%-29.72M | -43.45%-16.93M | 12.57%-28.18M | ---11.8M | -64.41%-32.23M | ---24M | -61.67%-19.6M | ---12.13M |
Revaluation surplus | ---- | ---- | ---- | 21,701.54%14.17M | --14.17M | --65K | ---- | ---- | ---- |
-Changes in the fair value of other assets | ---- | ---- | ---- | 21,701.54%14.17M | --14.17M | --65K | ---- | ---- | ---- |
Special items of operating profit | 388.38%11.14M | -324.62%-62.15M | 149.44%2.28M | -468.87%-14.64M | ---4.61M | -353.79%-2.57M | --4.7M | -119.81%-567K | --2.86M |
Operating profit | -104.11%-1.1M | -485.60%-48.56M | 595.41%26.64M | -80.30%12.59M | -5.38M | 9.51%63.92M | 46.73M | 41.93%58.37M | 41.13M |
Financing cost | 94.34%-229K | 9.37%-7.17M | -8.91%-4.05M | -18.38%-7.92M | ---3.72M | -38.88%-6.69M | ---4.87M | -17.01%-4.82M | ---4.12M |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---5.72M | ---- | ---- |
Earning before tax | -105.86%-1.32M | -1,291.64%-55.73M | 348.41%22.59M | -91.83%4.68M | -9.09M | 6.87%57.23M | 36.14M | 44.70%53.56M | 37.01M |
Tax | 100.28%11K | 59.49%-1.06M | -430.41%-3.93M | 68.26%-2.62M | ---740K | 4.01%-8.27M | ---4.97M | 3.78%-8.61M | ---8.95M |
After-tax profit from continuing operations | -107.03%-1.31M | -2,866.49%-56.8M | 289.80%18.67M | -95.81%2.05M | -9.83M | 8.95%48.97M | 31.17M | 60.17%44.94M | 28.06M |
Earning after tax | -107.03%-1.31M | -2,866.49%-56.8M | 289.80%18.67M | -95.81%2.05M | -9.83M | 8.95%48.97M | 31.17M | 60.17%44.94M | 28.06M |
Minority profit | ---486K | ---373K | ---- | ---- | ---- | ---- | ---- | ---- | ---2K |
Profit attributable to shareholders | -104.43%-827K | -2,848.32%-56.42M | 289.80%18.67M | -95.81%2.05M | -9.83M | 8.95%48.97M | 31.17M | 60.16%44.94M | 28.06M |
Basic earnings per share | -104.56%-0.0011 | -2,536.67%-0.0731 | 239.31%0.0241 | -96.52%0.003 | -0.0173 | 0.0861 | |||
Diluted earnings per share | -317.71%-0.0731 | -120.54%-0.0175 | -0.04 | 0.0852 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data